Our integrated and personalized approach

At neuroCare, we offer our patients sustainable outcomes in therapy for mental disorders, chronic pain and for rehabilitation. The individualised therapies offered at neuroCare clinics are achieved by integrating the expertise of  clinicians with leading neuromodulation technology. neuroConn is our technology brand, a global leader and industry pioneer in non-invasive neuromodulation. At neuroCademy we do research to further the quality of our care delivery as well as educate clinicians about neuromodulation and how to apply it in daily clinical practice.

Everything we do, think or feel is a memorized pattern in our brain or muscle memory. Neuromodulation helps to reprogram those patterns by training our mind to more positive behaviour or for better cognitive performance. Behavourial, cognitive or motor disturbances can be treated faster and more efficiently when neurotechnology and the therapist work in synergy. Our integrated approach (i.e. cognitive therapy combined with individualised neurotherapy) shows an efficacy of 75 % for patients with ADHD and an efficacy of 78 % for patients with depression. This is a fact we are truly proud of.

At neuroCare, we also apply neurotechnologies in the diagnosis of mental disorders allowing the therapist to personalize the treatment to the patient’s individual need - this is called prognostics.​​ Most current treatments in mental health or neurology, particularly psychopharmaceuticals, still rely on a one-size-fits-all approach. Individual differences are ignored even though not all patients have the same underlying cause for their symptoms. Our integrated and personalized approach to therapy is needed​.​ neuroCare is a leader in the fast growing neurotherapy market.​

More about the neuroCare Group

News

Concerns over 'Do-it-yourself' tDCS

Experts from the cognitive neuroscience research community have penned an open letter expressing their concern about members of the public applying electric current to the brain with home-use tDCS devices.

More News


Introduction to the neuroCare Group